leisure time -WSS

leisure time

author：entertainment 2025-09-29 16:46:01 - browse：474

Biotech startup Generate Biomedicines, which uses artificial intelligence to find new drugs, raised $273 million in a Series C funding round from investors including pharma company Amgen and the VC arm of AI giant NVIDIA.

Generate was founded in 2018 by venture-creation firm Flagship Pioneering to use machine learning algorithms to identify antibodies, peptides, cell therapies, and other medicines. It launched its first clinical trial in July for a Covid monoclonal antibody, and is working on starting another clinical trial for an asthma treatment.

The biotech, which is based in Somerville, Mass., has big plans for the next couple of years: It has another 15 drug candidates in the works and plans to introduce 10 more annually, CEO Mike Nally told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Bispecific antibodies are next new thing in cancer immunotherapy

entertainment

WSS

Bispecific antibodies are next new thing in cancer immunotherapy

Histogen: Failed biotech offers rare public look inside

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Novo: Oral version of Ozempic leads to 15% weight loss

knowledge

leisure time

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Phenylephrine and the overlooked value of the placebo effect

Guidelines to prevent youth baseball injuries need more muscle

A virus, fished out of a lake, may have saved a man’s life

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Xenotransplantation trials will require adjusting expectations, experts say

Peter Hotez and the public health issue of online harassment

Histogen: Failed biotech offers rare public look inside

Malaria cases in Florida and Texas: Here’s what you need to know

Colorectal cancer study finds potential in overlooked immune cell

explore

Mom launches Girl Scout troop for LGBTQ youth in Texas

How to fix the rural physician shortage in the U.S.

Altering the blood type of lungs raises potential for universal organs for transplants

Senate panel passes drug pricing bills, but drops one PBM reform

A Q&A with the global head of Boehringer Ingelheim's innovation unit

The future of health care in the House

entertainment

knowledge

knowledge

explore